White Papers
-
Optimizing Site Activation To Accelerate Clinical Trials
6/5/2025
Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.
-
Designing More Representative Trials Through Strategic Planning
5/28/2025
Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.
-
Expanding The Role Of External Control Arms
5/28/2025
External control arms (ECAs) are transforming clinical trials by enhancing efficiency, reducing costs, and addressing ethical challenges.
-
Why EHR Data Is The Game Changer For Life Sciences Success
5/26/2025
The pharmaceutical industry faces soaring costs and shrinking ROI. Discover why leveraging rich real-world data, especially from EHRs, is now essential for driving efficiency, innovation, and competitive advantage.
-
How AI Is Unlocking Healthcare Data To Transform Prostate Cancer Treatment
5/22/2025
As the global reliance on algorithms and artificial intelligence (AI) continues to grow, the importance of data quality and completeness has become a critical concern.
-
The Transformative Power For Non-Muscle Invasive Bladder Cancer Treatment
5/20/2025
Integrating AI with real-world urology data revolutionizes non-muscle invasive bladder cancer care to enable deeper insights into disease patterns, treatment outcomes, and personalized therapies.
-
IPF - Global Clinical Trial Landscape
5/19/2025
This report provides a comprehensive overview of Idiopathic Pulmonary Fibrosis (IPF), a progressive and fatal interstitial lung disease.
-
Accelerate Drug Development With Master Protocols
5/15/2025
Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
A Strategic Guide For Biotech And Biopharma Leaders
5/15/2025
Securing drug approval is a complex, high-stakes process. Explore how outdated document review workflows hinder progress and how modern solutions can accelerate timelines without compromising compliance or quality.
-
Infectious Diseases - Global Clinical Trial Landscape (2025)
5/14/2025
The global infectious disease clinical trial landscape has rapidly expanded between 2020 and 2024, driven by the urgency of emerging threats, technological innovation, and evolving regulatory frameworks.